Presented at the Regular Academic Conference of the Seoul Internal Medicine Society

JW Pharmaceutical announced on July 31 that it recently held a lecture at the regular academic conference of the Seoul Internal Medicine Society, which took place at Lotte Hotel Seoul in Jung-gu, Seoul, to share the clinical benefits of its comprehensive nutritional injection, Winuf Injection.


At this lecture, Moon Eulseon, Director of Olive Internal Medicine Clinic, gave a presentation on "Clinic-Tailored Treatment for Enteritis." He introduced the molecular biological anti-inflammatory mechanisms of Winuf, an omega-3 containing nutritional infusion (TPN), as well as infusion therapy strategies for patients with acute enteritis.


JW Pharmaceutical recently held a lecture on the topic of 'Clinic-tailored Treatment for Enteritis' at the regular academic conference of the Seoul Internal Medicine Society, held at Lotte Hotel Seoul in Jung-gu, Seoul. JW Pharmaceutical

JW Pharmaceutical recently held a lecture on the topic of 'Clinic-tailored Treatment for Enteritis' at the regular academic conference of the Seoul Internal Medicine Society, held at Lotte Hotel Seoul in Jung-gu, Seoul. JW Pharmaceutical

View original image

Director Moon noted that for patients with organic inflammatory enteritis accompanied by symptoms such as diarrhea, abdominal pain, myalgia, and high fever, a simple symptom-suppression approach using NSAIDs has limitations. He shared a treatment method that involves the administration of Winuf Peri Injection to promote fundamental resolution of inflammation. In particular, he emphasized that, for patients with enteritis experiencing high fever and acute catabolism, a treatment approach focused on resolving inflammation is essential.



JW Pharmaceutical plans to strengthen academic activities and provide medical information for healthcare professionals based on the clinical evidence supporting Winuf Injection.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing